Live Breaking News & Updates on Primary Outcomes

Stay updated with breaking news from Primary outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

United States , Anniversary Of American College Cardiology , Symposium Of The Heart Rhythm Society , Clinical Research , Medication Management Program To Reduce , American Heart Association , American College Of Cardiology Session , Risk Factors Among National Football League Alumni , American College Of Cardiology , Georgia World Congress Center , Health Status In Heart Failure Clinic Trial , Outcomes After Technology Assisted Nonprescription Rosuvastatin Administration , American College , Annual Scientific Session , Georgia World Congress , Cardiovascular Care , Late Breaking Clinical Trial , Featured Clinical Research , Investigative Horizons , Scientific Sessions , Guidelines Sessions , Guidelines Tell Us About Practical Management , Joint Symposium , Heart Rhythm Society , From Prediction , Aorta Strikes Back ,

SEL-212 Shows Significant Response Rates, sUA Reductions in Patients with Gout

Investigators believe targeted immunomodulation with SEL-212 may have the potential to introduce a new uricase-based therapy for patients with gout refractory to conventional treatment. ....

United States , San Diego , Herbert Baraf , George Washington University , American College Of Rheumatology , Bone Research , National Institute Of Arthritis , National Institute , Skin Diseases , Gout Refractory , Conventional Treatment , Primary Outcomes , Two Randomized , Double Blind , Multicenter Phase , American College ,

TCT23 Late-breakers: Full Schedule Announced

Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26 ....

United States , San Francisco , Suzannev Arnold , Davide Kandzari , Robertl Smith , Davidh Adams , Amitn Vora , Susheelk Kodali , Joanna Chikwe , Suzannej Baron , Firas Zahr , Anitaw Asgar , Tobias Koch , Mirvat Alasnag , Roberto Bonow , Robertw Yeh , Debbie Cohen , Gorav Ailawadi , Marco Valgimigli , Samirr Kapadia , Stephan Windecker , Shaoliang Chen , Tamimm Nazif , Roberto Galea , Juanf Granada , Saif Anwaruddin ,

Global Idiopathic Pulmonary Fibrosis Market Report 2022 - Strategic Opportunities Windows and Assessment of Unmet Needs

/PRNewswire/ The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to. ....

United Kingdom , Boehringer Ingelheim Pharma Gmb , Chong Kun Dang , Esbriet Pirfenidone , Boehringer Ingelheim Gmb , Chongkun Dangpharmaceutical , Prometic Lifesciences , Ofev Nintedanib , Laura Wood , Celgene Corporation , Nitto Denko Corporation , Biogen Inc , Boehringer Ingelheim Pharma Gmbh Co , National Organization For Rare Disorder , Product Development Innovation , Clinical Development , Market Development , Promedior Inc , Office Hours Call , Genentech Inc , E St Office Hours Call , National Institute For Health , Bionews Inc , Kadmon Corporation , Second Wind Lung Transplant Association Inc , Pulmonary Fibrosis Foundation ,

Global Idiopathic Pulmonary Fibrosis Market Report 2022 - Strategic Opportunities Windows and Assessment of Unmet Needs

/PRNewswire/ The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to. ....

United Kingdom , Boehringer Ingelheim Pharma Gmb , Chong Kun Dang , Esbriet Pirfenidone , Boehringer Ingelheim Gmb , Chongkun Dangpharmaceutical , Prometic Lifesciences , Ofev Nintedanib , Laura Wood , Celgene Corporation , Nitto Denko Corporation , Biogen Inc , Boehringer Ingelheim Pharma Gmbh Co , National Organization For Rare Disorder , Product Development Innovation , Clinical Development , Market Development , Promedior Inc , Office Hours Call , Genentech Inc , E St Office Hours Call , National Institute For Health , Bionews Inc , Kadmon Corporation , Second Wind Lung Transplant Association Inc , Pulmonary Fibrosis Foundation ,